JN.1, the current SARS-CoV-2 version, now accounts for about 50% of all cases in the United States. Because of its anomalies, this vaccinologist believes we'' ll soon see a striking distinction in how future variations impact healthy unjabbed individuals vs. those keeping up to date on their booster shots.